Market Cap (In CAD)
147.77 Million
Revenue (In CAD)
29.81 Thousand
Net Income (In CAD)
-11.7 Million
Avg. Volume
50.56 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.75-2.12
- PE
- -
- EPS
- -
- Beta Value
- 0.763
- ISIN
- CA98942X1024
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Gregory Fenton C.F.A.
- Employee Count
- -
- Website
- https://www.zentek.com
- Ipo Date
- 2010-12-23
- Details
- Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.
More Stocks
-
4770Zuken Elmic, Inc.
4770
-
2715Elematec Corporation
2715
-
NVX
-
HSY
-
CNX
-
DNOWNOW Inc.
DNOW
-
LTSK
-
PDSB